If your weight loss goals have taken a backward step, this simple device might be all you need to get back on track and shed ...

In addition, this drug can cause nausea or decreased appetite, which can lead to weight loss. Mounjaro contains the active ingredient tirzepatide ... use prefilled pen. You’ll inject Mounjaro ...

The author of a new guidebook on GLP-1s and other experts share their tips for how clinicians can optimize patient success ...

An Air Force F-35 fighter jet crashed on Tuesday during a training mission in central Alaska. Officials say the crash ...

FDA formally announced the end of the tirzepatide shortage in a Declaratory Order issued to Eli Lilly & Co. (“Lilly”). Lilly ...

The newest weight-loss drugs, Wegovy and Zepbound, are incredibly popular. But doctors are still learning about all of the ...

Zepbound is a once-weekly injectable medication that contains the same active ingredient as Mounjaro: tirzepatide. However, unlike Mounjaro and Ozempic, Zepbound is FDA approved for weight loss in ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...

NPA chairman Nick Kaye told the PA news agency that while obesity is "one of the biggest challenges facing" the UK, they are ...